These amazing findings imply that recognition of lipid antigens by mouse CD1d-restricted T cells largely evolved in the context of innate rather than adaptive immunity

These amazing findings imply that recognition of lipid antigens by mouse CD1d-restricted T cells largely evolved in the context of innate rather than adaptive immunity. Materials and Methods Mice. C57BL/6 mice were from Taconic Farms. more closely resemble additional lineages of innate lymphocytes such as B-1 B cells, T cells, and NK cells, which communicate invariant or semiinvariant autoreactive receptors. Finally, we demonstrate the MHC-restricted TCR repertoire is essentially nonCcross-reactive to CD1d. Altogether, these findings imply that lipid acknowledgement by CD1d-restricted T cells may have mainly developed as an innate rather than an adaptive arm of the mouse immune system. exhibited detectable CD1c-restricted T cell reactions to a semisynthetic isoprenoid glycolipid resembling natural mycobacterial antigens 16. Additional studies have also suggested some diversity in both TCR repertoire and antigenic specificities 17 18 19 20 21 22 23. The coexistence of innate and adaptive TCR acknowledgement would be a unique and interesting aspect of the CD1 system, likely to have important evolutionary implications for the protecting value of lipid, as opposed to peptide, recognition. Consequently, we set out to define the respective sizes of the adaptive and innate T cell populations associated with CD1d, the only CD1 isotype indicated in mice, and the one shared by most, though perhaps not all 24, mammals thus far examined. To search for a varied, adaptive human population of CD1d-restricted T cells, we quantitatively examined the contribution of CD1d to the selection of CD4, CD8, and DN T cells by comparing the size and composition of the residual T cell populations in mice deficient for MHC (which lack mainstream T cells) versus mice doubly deficient for MHC and CD1d (which lack both the mainstream T cells and AF-353 the CD1d-dependent T cells). By using fluorescent tetramers of CD1d1/GalCer complexes to specifically determine V14 T cells, we were able to focus on the nonCV14-centered T cell human population, determine its size and phenotype, and analyze its TCR repertoire. Further, we explored the possibility that classical AF-353 MHC molecules might select T cells able to cross-react with CD1d that would contribute to the CD1d-restricted repertoire. Our results indicate the mouse CD1d-restricted TCR repertoire is limited in both size and diversity. It is dominated by cells bearing a few recurrent semiinvariant TCRs that show the hallmarks of self-antigenCdriven selection and the same natural AF-353 memory space NKT phenotype as V14 NKT cells. These amazing findings imply that acknowledgement of lipid antigens by mouse CD1d-restricted T cells mainly evolved in the context of innate rather than adaptive immunity. Materials and Methods Mice. C57BL/6 mice were from Taconic Farms. Mice deficient in KbDb or transporter associated with antigen demonstration (Faucet)-1 (referred to as MHC class I deficient), Rabbit Polyclonal to TSPO I-Ab (MHC class II deficient), CD1d1, or CD1d1/CD1d2 (CD1d deficient), and their crosses were used after 7C13 backcrosses to C57BL/6 25. All the results reported with this study AF-353 were derived from comparative analysis of littermates expressing ?/? versus +/? or +/+ genotypes. All mice were raised in a specific pathogen-free barrier environment at Princeton University or college, according to institutional animal care and use recommendations. Circulation Cytometry Studies and Monoclonal Antibodies. To obtain liver or lung lymphocytes, the organs were 1st cut into small pieces and approved through a nylon mesh in PBS/1% BSA, then the cell suspension was centrifuged over a coating of Ficoll-Paque? (Amersham Pharmacia Biotech) and the lymphocytes were collected in the interface between Ficoll and PBS-BSA. Fluorochrome or biotin-conjugated anti-pan TCR-, V8.1/8.2, V7, V2, V6, V3.2, CD44, CD69, CD122, CD4, CD8, CD5, NK1.1, and warmth stable antigen were from BD PharMingen, as well as streptavidin-Cychrome, -allophycocyanin, or -PE. Anti-V8 monoclonal antibodies including KT 50, KT 65, and B21.14 26 27 were from BD PharMingen and through Dr. B.J. Fowlkes (National Institutes of Health, Bethesda, MD). Samples were analyzed using a FACS Vantage? (Becton Dickinson) equipped with argon and dye lasers, or perhaps a four-color FACSort? equipped with argon and 635-nm diode lasers (Becton Dickinson), and CELLQuest? software. CD1d1/GalCer Tetramers. Recombinant soluble CD1d1 molecules having a biotinylation sequence were produced in a take flight expression system, purified, and biotinylated as reported previously 28. Soluble biotinylated recombinant CD1d1 molecules were incubated for 18 h having a 2 M stock remedy of GalCer in 0.5% Tween 20, and free GalCer was eliminated by centrifugation dialysis inside a Microcon YM-30 tube (Millipore). Tetramers were generated by combining GalCer-loaded monomers with fluorochrome-labeled streptavidin (streptavidin-PE, streptavidin-allophycocyanin, or streptavidin-Cychrome.